Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Incidence of malaria among mosquito collectors conducting human landing catches in western Kenya.

Gimnig JE, Walker ED, Otieno P, Kosgei J, Olang G, Ombok M, Williamson J, Marwanga D, Abong'o D, Desai M, Kariuki S, Hamel MJ, Lobo NF, Vulule J, Bayoh MN.

Am J Trop Med Hyg. 2013 Feb;88(2):301-8. doi: 10.4269/ajtmh.2012.12-0209. Epub 2012 Dec 18.

2.

Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.

Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR.

Clin Infect Dis. 1998 Sep;27(3):494-9.

PMID:
9770146
3.

No difference in the incidence of malaria in human-landing mosquito catch collectors and non-collectors in a Senegalese village with endemic malaria.

Wotodjo AN, Trape JF, Richard V, Doucouré S, Diagne N, Tall A, Ndiath O, Faye N, Gaudart J, Rogier C, Sokhna C.

PLoS One. 2015 May 12;10(5):e0126187. doi: 10.1371/journal.pone.0126187. eCollection 2015.

4.

Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.

Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J, Sousa JC, Dumler JS, Magill AJ.

Clin Infect Dis. 2012 Jan 15;54(2):232-9. doi: 10.1093/cid/cir770. Epub 2011 Nov 3.

PMID:
22052893
5.

A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.

Mavrogordato A, Lever AM.

J Infect. 2012 Sep;65(3):269-74. doi: 10.1016/j.jinf.2012.04.015. Epub 2012 May 16.

PMID:
22609735
6.

Atovaquone and proguanil hydrochloride for prophylaxis of malaria.

Shanks GD, Kremsner PG, Sukwa TY, van der Berg JD, Shapiro TA, Scott TR, Chulay JD; Malarone Clinical Trials Study Group.

J Travel Med. 1999 May;6 Suppl 1:S21-7. Review.

8.

The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].

van Genderen PJ, Koene HR, Spong K, Overbosch D.

J Travel Med. 2007 Mar-Apr;14(2):92-5. Erratum in: J Travel Med. 2007 May-Jun;14(3):203.

9.

Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.

Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL; Naval Medical Research Unit 2 Clinical Trial Team.

Clin Infect Dis. 2002 Oct 1;35(7):825-33. Epub 2002 Sep 11.

PMID:
12228819
10.

Atovaquone and proguanil hydrochloride for treatment of malaria.

Kremsner PG, Looareesuwan S, Chulay JD.

J Travel Med. 1999 May;6 Suppl 1:S18-20. Review.

11.

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.

Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.

Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.

12.

Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.

Kato T, Okuda J, Ide D, Amano K, Takei Y, Yamaguchi Y.

J Infect Chemother. 2013 Feb;19(1):20-3. doi: 10.1007/s10156-012-0446-z. Epub 2012 Jun 29.

PMID:
22740189
13.

Azithromycin for treating uncomplicated malaria.

van Eijk AM, Terlouw DJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006688. doi: 10.1002/14651858.CD006688.pub2. Review.

PMID:
21328286
14.
15.

Risk of Plasmodium falciparum infection during a malaria epidemic in highland Kenya, 1997.

John CC, Koech DK, Sumba PO, Ouma JH.

Acta Trop. 2004 Sep;92(1):55-61.

PMID:
15301975
16.

Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.

Am J Trop Med Hyg. 2007 Apr;76(4):655-8.

PMID:
17426165
17.

Atovaquone + proguanil: new preparation. Second-line antimalarial combination.

[No authors listed]

Prescrire Int. 2002 Oct;11(61):131-6.

PMID:
12378742
18.

Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.

Bouchaud O, Mühlberger N, Parola P, Calleri G, Matteelli A, Peyerl-Hoffmann G, Méchaï F, Gautret P, Clerinx J, Kremsner PG, Jelinek T, Kaiser A, Beltrame A, Schmid ML, Kern P, Probst M, Bartoloni A, Weinke T, Grobusch MP.

Malar J. 2012 Jun 22;11:212. doi: 10.1186/1475-2875-11-212.

19.

Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.

Kimura M, Koga M, Kikuchi T, Miura T, Maruyama H.

Parasitol Int. 2012 Sep;61(3):466-9. doi: 10.1016/j.parint.2012.03.004. Epub 2012 Mar 29.

PMID:
22484597
20.

Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).

Boggild AK, Parise ME, Lewis LS, Kain KC.

Am J Trop Med Hyg. 2007 Feb;76(2):208-23.

PMID:
17297027

Supplemental Content

Support Center